$0.01
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+134,900.0% upside
Low Target
$9.80
Average Target
$13.50
High Target
$19.20
Current Price
$0.01
Current
$0.01
$0.01
Target
$13.50
$13.50
$9.80
$13.50 avg
$19.20
Scenario Analysis
Bear Case
$9.80
97,900.0%
Low target
Base Case
$13.50
+134,900.0%
Avg target
Bull Case
$19.20
+191,900.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
Target vs 52W High
$13.50
-99.6% vs high
Next Earnings Report
Nov 16, 2026
9d
until earnings
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |